This is a One-day Liver Symposium symposium in Toronto on pediatric hepatocellular carcinoma and advanced hepatoblastoma, for pediatric oncologists, surgeons and allied health care professionals involved in the care of children with advanced liver tumours.
The goal of this workshop is to develop Canadian Guidelines on the Management of Advanced Liver Tumours in Children. This is a multidisciplinary effort between pediatric oncology, surgery, gastroenterology and the transplant team. One of the major focuses will be on the indications for liver transplant in high risk situations.
Objectives: We are hoping to have focused talks and discussion in order to address our
ultimate goal which is to establish guidelines for the treatment of children with advanced HCC and HB. SPEAKERS:
Dr. Marcio Malogolowkin,
Division Head, Hematology-Oncology for Clinical Affairs & Clinical Research;Director,
Bone & Soft Tissue Tumor Program Associate Professor of Pediatrics
Children’s Hospital Los Angeles
Dr. Rebecka Meyers
Chief, Division of Pediatric Surgery
Professor of Surgery and Adjunct Professor of Pediatrics
University of Utah School of Medicine
Dr. Tomoaki Kato
Surgical Director, Division of Abdominal & Intestinal Organ Transplantation
Vice President-System Capacity & Perioperative Operations –
Columbia University Medical Center/ Morgan Stanley Children's Hospital
0800 Breakfast
0830 Welcome/Introduction/General Overview - Dr. Ronald Grant 0845 The Role for Chemotherapy in Advanced HCC
- Introduction/Case presentation -Dr. Ronald Grant
- Dr. Marcio Malogolowkin: Children with HCC Should receive systemic chemotherapy
- Dr. Abha Gupta: Children with HCC Should NOT receive systemic chemotherapy Group Discussion 1045 Coffee Break 1100 The Role of Liver Transplantation in HCC, Beyond the Milan Criteria
- Introduction/Case Presentation - Dr. Vicky Ng
- Dr. Tomoaki Kato: Children beyond Milan should be offered liver transplantation - ie. extrahepatic mets, vascular invasion, size
- Dr. David Grant: Children beyond Milan should NOT be offered liver transplantation
Group Discussion 1300 Lunch Break 1400 The Role of Liver Transplantation in Advanced Hepatoblastoma
- Dr. Ted Gerstle; Case presentation/Introduction
- Dr. Rebecka Meyers: Children with Metastatic HB should be offered Liver Transplantation
- Annie Fecteau: Children with Metastatic HB should NOT be offered Liver Transplantation Group Discussion 1600 Coffee Break 1615-1800 Summary/Discussion - Attendees and speakers will be separated into 3 groups to discuss the above 3 questions and compose a point-form draft of the consensus statement that will later be edited and included in our final set of guidelines | 
